Happy Wednesday!

GameStop has disclosed its first tranche of Bitcoin acquisitions, and it was a significant one: here’s how much the company bought.

Strategy and Metaplanet continue to acquire Bitcoin, but the pace is slowing: what is going on?

Plus, an exclusive can’t-miss opportunity to explore a groundbreaking innovation that could reshape how diabetes is managed — join us for an inside look at Glucotrack (GCTK), a cutting-edge medical technology company pushing the boundaries of continuous glucose monitoring (CGM).

Join leading experts and company insiders to get a first-hand look at a technology that could change the game for millions living with diabetes. Register now!

TOP STORY

GameStop Buys 4,710 Bitcoins — Here's Why Markets Are Watching

GameStop shares surged Wednesday in premarket trading after the company announced the purchase of 4,710 Bitcoins, marking a significant step in its pivot toward digital assets.

This acquisition follows GameStop’s earlier decision to adopt Bitcoin as a treasury reserve asset, a move confirmed during its fourth-quarter earnings release.

As of May 27, 2025, the leading cryptocurrency briefly surged above $110,000 before retreating to the $108,000 range overnight. GameStop did not disclose the average purchase price of its 4,710 Bitcoins.

What is GameStop’s plan for the future?

Read the full scoop here.

SPECIAL OFFER

Revolutionizing Diabetes Care: Discover The Future Of Continuous Glucose Monitoring

Don’t miss this exclusive opportunity to explore a groundbreaking innovation that could reshape how diabetes is managed. Join us for an inside look at Glucotrack (NASDAQ: GCTK), a cutting-edge medical technology company pushing the boundaries of continuous glucose monitoring (CGM).

🔍 What You’ll Learn:

• How CBGM technology works—and how it could transform life for people with diabetes

• The critical role of real-time, continuous blood glucose tracking

• Why the current CGM landscape needs a bold new solution

• Highlights from Glucotrack’s first-in-human clinical trial

• What’s next: details on the newly announced long-term clinical study

When: Thursday, 5/29 at 11:00 am EST

Join leading experts and company insiders to get a first-hand look at a technology that could change the game for millions living with diabetes. Register now!

This is a paid ad. Please see 17b disclosure here for more information.

QUICK N DIRTY

Dogecoin is down, and concerns about a liquidation cascade are growing. Here is everything you need to know about DOGE today.

Donald Trump and his family are getting increasingly involved in crypto. Here are all the projects they have started or support so far.

Telegram is going to raise $1.5 billion in bonds, despite company CEO Pavel Durov’s legal trouble in France. Here are the details.

FINTECH FOCUS

Strategy, Metaplanet Continue Bitcoin Treasury Push But The Pace Is Slowing

Two of the most prominent corporate backers of Bitcoin, Strategy and Japan-based Metaplanet, are continuing their BTC acquisition strategies.

Strategy revealed earlier this week that it had acquired 4,020 more bitcoins for approximately $427.1 million between May 19 and May 25.

Metaplanet, often likened to Strategy in the Asian market, is also pressing forward.

The Tokyo-listed firm has issued $50 million in zero-interest bonds, its 16th such issuance, to fuel further BTC accumulation.

But there is a catch.

What exactly?

Read the full scoop here.

BEFORE YOU GO

Were you forwarded this email? Click here to subscribe.

And be sure to check out our other newsletters:

Ring The Bell: Created for market enthusiasts by market enthusiasts, this daily newsletter delivers top stories, fast movers and hot trade ideas straight to your inbox. Subscribe here.

Cannabis Daily: A must-read daily briefing for cannabis investors, operators and enthusiasts. Join our list of industry veterans to jump start your morning. Subscribe here.

Advisor: Tailor-made for Financial Advisors, this weekly newsletter has industry-specific insights, analysis and news. Subscribe here.

Tech Trends: Get the inside scoop on AI, the hottest gadgets and mind-blowing tech trends. Subscribe here.

Disclaimer: This communication from Benzinga is for informational purposes only. It is not intended to serve as a recommendation to buy, sell, or hold any security and is not an offer or sale of a security. Information contained within should not be perceived as a research report and is not intended to serve as the basis for any investment decision. Any third-party views reflected herein do not reflect the opinion of Benzinga. All investments involve risk and the past performance of a security does not guarantee future results or returns. There is always the potential for financial loss when investing in securities or other financial products. Investors should consider their investment objectives and risks before investing. Benzinga is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Benzinga may receive monetary compensation from the issuer, or its agency, for publicizing the offering of the issuer’s securities. This content is for informational purposes only and is not intended to be investing advice. This is a paid ad. Please see 17b disclosure linked in the campaign page for more information.